IFNG and tuberculosis: The primary rationale for the development of TB vaccines designed to elicit Th1-cell-based immunity is based on evidence from various animal models that a strong IFN-γ-mediated Th1 immune response is the primary protective mechanism of anti-TB immunity [19,35,42,43,44,45].